Markers of Response to Antiangiogenic Therapies in Colorectal Cancer: Where Are We Now and What Should Be Next?

Despite advances in the treatment of colorectal cancer (CRC), it remains the second most common cause of cancer-related death in the Western world. Angiogenesis is a complex process that involves the formation of new blood vessels from preexisting vessels. It is essential for promoting cancer surviv...

Descripción completa

Detalles Bibliográficos
Autores principales: Cidon, E. Una, Alonso, P., Masters, B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Libertas Academica 2016
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849423/
https://www.ncbi.nlm.nih.gov/pubmed/27147901
http://dx.doi.org/10.4137/CMO.S34542

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4849423/
https://www.ncbi.nlm.nih.gov/pubmed/27147901
http://dx.doi.org/10.4137/CMO.S34542

Ejemplares similares